Health Trials

Resectable Stage II-III Non-small Cell Lung Cancer

1

Review clinical trials related to Resectable Stage II-III Non-small Cell Lung Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer

This is a Phase 2 study to evaluate the safety, and efficacy of IBI363 as Neoadjuvant Therapy in Resectable Stage II-III Non-Small Cell Lung Cancer.

Participants needed: 10
Trial details
Phase: Phase 2Age: 18-75Biological sex: AllType: InterventionalSponsor: Innovent Biologics (Suzhou) Co. Ltd.Updated: Feb 11, 2026Locations: 1
Eligibility criteria

Males and Females, age ≥18 years and ≤75 years; [+8]

Histologically confirmed the presence of small cell lung cancer, neuroendocrine... [+10]

Read more